Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
Biohaven Pharmaceutical Holding Company Ltd
Short-Term Debt
Biohaven Pharmaceutical Holding Company Ltd
Short-Term Debt Peer Comparison
Competitive Short-Term Debt Analysis
Latest Figures & CAGR of Competitors
Company | Short-Term Debt | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Biohaven Pharmaceutical Holding Company Ltd
NYSE:BHVN
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Abbvie Inc
NYSE:ABBV
|
Short-Term Debt
$3m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-64%
|
CAGR 10-Years
4%
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Amgen Inc
NASDAQ:AMGN
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Short-Term Debt
$0
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Biohaven Pharmaceutical Holding Company Ltd's Short-Term Debt?
Short-Term Debt
0
USD
Based on the financial report for Dec 31, 2023, Biohaven Pharmaceutical Holding Company Ltd's Short-Term Debt amounts to 0 USD.